Safety and Immunogenicity of VLA2001 Adults Aged ≥56 Years

Clinical trial NCT04956224 · COMPLETED

Trial details

NCT number: NCT04956224
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Virus Infection

Start date: 2021-08-09
Primary completion: 2021-11-10
Enrollment: 306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.